OBJECT: Magnetic resonance imaging (MRI) is the gold standard non-invasive technique to detect malignant disease in the bone marrow. Proton magnetic resonance spectroscopy (MRS) can be performed as a quick adjunct to routine spinal MRI. We performed proton MRS to patients with multiple myeloma (MM) at diagnosis and after treatment to investigate the possible correlation of MRS data with response to therapy. PATIENTS AND METHODS: Twenty-one patients with newly diagnosed MM underwent combined MRI/MRS explorations of a transverse center section in the fifth lumbar vertebral body. MRS was acquired with STEAM and 40 ms TE. Areas of unsuppressed water and lipid resonances were used to calculate the lipid-to-water ratio (LWR). RESULTS: No association was detected between initial LWRs and the clinical characteristics of patients. Post treatment MRS was available in 16 patients of whom 11 (69%) presented an LWR increase, this included all complete responders (8/8, 100%, P = 0.012). A post-treatment LWR value equal to or larger than one is proposed as a non-invasive marker of complete response to treatment. CONCLUSION: Only patients responding to treatment presented a significant increase in bone marrow LWR after therapy. MRS may provide an adequate quantification of response to chemotherapy in patients with MM.
OBJECT: Magnetic resonance imaging (MRI) is the gold standard non-invasive technique to detect malignant disease in the bone marrow. Proton magnetic resonance spectroscopy (MRS) can be performed as a quick adjunct to routine spinal MRI. We performed proton MRS to patients with multiple myeloma (MM) at diagnosis and after treatment to investigate the possible correlation of MRS data with response to therapy. PATIENTS AND METHODS: Twenty-one patients with newly diagnosed MM underwent combined MRI/MRS explorations of a transverse center section in the fifth lumbar vertebral body. MRS was acquired with STEAM and 40 ms TE. Areas of unsuppressed water and lipid resonances were used to calculate the lipid-to-water ratio (LWR). RESULTS: No association was detected between initial LWRs and the clinical characteristics of patients. Post treatment MRS was available in 16 patients of whom 11 (69%) presented an LWR increase, this included all complete responders (8/8, 100%, P = 0.012). A post-treatment LWR value equal to or larger than one is proposed as a non-invasive marker of complete response to treatment. CONCLUSION: Only patients responding to treatment presented a significant increase in bone marrow LWR after therapy. MRS may provide an adequate quantification of response to chemotherapy in patients with MM.
Authors: Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin Journal: J Clin Oncol Date: 2005-04-04 Impact factor: 44.544
Authors: B C Van de Berg; F E Lecouvet; L Michaux; M Labaisse; J Malghem; J Jamart; B E Maldague; A Ferrant; J L Michaux Journal: Radiology Date: 1996-10 Impact factor: 11.105
Authors: A Devos; L Lukas; J A K Suykens; L Vanhamme; A R Tate; F A Howe; C Majós; A Moreno-Torres; M van der Graaf; C Arús; S Van Huffel Journal: J Magn Reson Date: 2004-09 Impact factor: 2.229
Authors: Deep K Hathi; John A Engelbach; Jens Hillengass; Deborah Veis; Samuel Achilefu; Joel R Garbow; Monica Shokeen Journal: NMR Biomed Date: 2019-06-17 Impact factor: 4.044
Authors: Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Lorenzo Nardo; Daniel Kuo; Andrew J Burghardt; Umesh B Masharani; Ann V Schwartz; Xiaojuan Li; Thomas M Link Journal: J Magn Reson Imaging Date: 2011-08-16 Impact factor: 4.813
Authors: Ty K Subhawong; Xin Wang; Daniel J Durand; Michael A Jacobs; John A Carrino; Antonio J Machado; Laura M Fayad Journal: AJR Am J Roentgenol Date: 2012-01 Impact factor: 3.959
Authors: Thomas Baum; Alexander Rohrmeier; Jan Syväri; Maximilian N Diefenbach; Daniela Franz; Michael Dieckmeyer; Andreas Scharr; Hans Hauner; Stefan Ruschke; Jan S Kirschke; Dimitrios C Karampinos Journal: Front Endocrinol (Lausanne) Date: 2018-04-04 Impact factor: 5.555
Authors: Michael Dieckmeyer; Daniela Junker; Stefan Ruschke; Muthu Rama Krishnan Mookiah; Karupppasamy Subburaj; Egon Burian; Nico Sollmann; Jan S Kirschke; Dimitrios C Karampinos; Thomas Baum Journal: Front Endocrinol (Lausanne) Date: 2020-10-15 Impact factor: 5.555